Company Overview

Launched in Nov 1995

to serve the strategic and compliance needs of pharmaceutical manufacturers.

of pharmaceutical industry experience

including systems, distribution, finance, managed markets, government pricing, channel dynamics and compliance functional areas.

in Revenue Leakage identified using S•E•T’s proprietary models to identify product diversion and duplicate 340B discounts

in fines and penalties avoided due to S•E•T’s discovery and interactions with the United States Department of Justice

in annual Net Profit increases through S•E•T’s Portfolio Optimization Projects

by S•E•T Enterprises ranging from one product to over 1,200 products and from 8,000 transactions to over 45 million transactions.

Mr. Winterton personally delivers all consulting services for S•E•T Enterprises and is known for his ability to analyze extremely large volumes of data and synthesize his findings into impactful, easy to understand and actionable results.